SOURCE: Fresh Start Private Management Inc.

Fresh Start Private Management Inc.

November 23, 2010 12:37 ET

Fresh Start Private Management Inc. Enters Intellectual Property License and Asset Purchase Agreement

LOS ANGELES, CA--(Marketwire - November 23, 2010) - Fresh Start Private Management Inc. (OTCBB: CEYY), a leader in the alcohol treatment and rehabilitation industry, today announced that it has entered into an agreement with Fresh Start Private Inc. that was subsequently filed as an 8K with the SEC.

Under the terms of the agreement, Fresh Start Private Management, Inc. (FSPM) has entered into an Intellectual Property License and Asset Purchase Agreement with Fresh Start Private Inc., a private Nevada Company in the alcohol treatment business.

Under the terms of the Agreement FSPM will own all assets and have exclusive rights in the United States of America for Fresh Start Private Inc.'s alcohol treatment program and methodology.

See the 8K filed with the SEC for more information.

About Fresh Start Private
Fresh Start Private is an alcohol addiction, alcohol withdrawal, alcohol abuse treatment and alcohol detox rehabilitation company on the leading edge of addiction treatment. The Company has developed a patented highly effective treatment delivers target therapeutic levels of Naltrexone that significantly reduce patients' cravings for alcohol. To date, more than 5,000 patients have received the Fresh Start Private Naltrexone implant.

For more information visit www.freshstartprivate.com

The information in this release includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Although the company believes that its expectations are based on reasonable assumptions, actual results may differ materially. These forward-looking statements involve risks and uncertainties that include, among others, market demand for, and/or available supplies of products and services; unanticipated delays, risks related to competition, management of growth, new products, services and technologies, potential fluctuations in operating results, commercial agreements, acquisitions and strategic transactions, government regulation and taxation. More information about factors that potentially could affect the Company's financial results is included in its filings with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information

  • Contact
    Dr. Jorge Andrade
    714-514 6100